These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20051756)

  • 41. Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis.
    Torre-Cisneros J; Del Castillo M; Castón JJ; Castro MC; Pérez V; Collantes E
    Rheumatology (Oxford); 2005 Sep; 44(9):1132-5. PubMed ID: 15927999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab.
    Bassetti M; Pizzorni C; Gradoni L; Del Bono V; Cutolo M; Viscoli C
    Rheumatology (Oxford); 2006 Nov; 45(11):1446-8. PubMed ID: 16887847
    [No Abstract]   [Full Text] [Related]  

  • 43. Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature.
    De Leonardis F; Govoni M; Lo Monaco A; Trotta F
    Clin Exp Rheumatol; 2009; 27(3):503-6. PubMed ID: 19604446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A patient with rheumatoid arthritis, cryoglobulinaemia, and an "accidental" finding.
    Liapis K; Chung Y; Akhtar W; Taussig D
    BMJ; 2014 Apr; 348():g2701. PubMed ID: 24733745
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-α antagonists.
    Neumayr AL; Morizot G; Visser LG; Lockwood DN; Beck BR; Schneider S; Bellaud G; Cordoliani F; Foulet F; Laffitte EA; Buffet P; Blum JA
    Travel Med Infect Dis; 2013; 11(6):412-20. PubMed ID: 23972958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psoriasiform eruption associated with alopecia areata during infliximab therapy.
    Nakagomi D; Harada K; Yagasaki A; Kawamura T; Shibagaki N; Shimada S
    Clin Exp Dermatol; 2009 Dec; 34(8):923-4. PubMed ID: 19438542
    [No Abstract]   [Full Text] [Related]  

  • 47. [Infectious complications in patients treated with anti-TNF-alpha: two cases of leishmaniasis].
    Bousquet E; Mura F; Villain M; Rivière S; Konate A; Schneider C
    J Fr Ophtalmol; 2012 Nov; 35(9):695-9. PubMed ID: 22925844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of infliximab use during pregnancy.
    Djokanovic N; Klieger-Grossmann C; Pupco A; Koren G
    Reprod Toxicol; 2011 Jul; 32(1):93-7. PubMed ID: 21621603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disseminated histoplasmosis causing splenic rupture in a patient receiving infliximab.
    Khalil Q; Abbass K; Kibria R; Agrawal S
    Acta Gastroenterol Belg; 2011 Mar; 74(1):101-2. PubMed ID: 21563665
    [No Abstract]   [Full Text] [Related]  

  • 50. [Visceral leishmaniasis (two case reports)].
    Benes J; Kabelková M; Holecková P; Kozák T; Benesová K; Mikulenková D; Nohýnková E
    Klin Mikrobiol Infekc Lek; 2012 Apr; 18(2):43-7. PubMed ID: 22997777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visceral leishmaniasis in a patient with systemic juvenile arthritis treated by IL-1RA agonist (Anakinra).
    Koné-Paut I; Retornaz K; Garnier JM; Bader-Meunier B
    Clin Exp Rheumatol; 2007; 25(1):119. PubMed ID: 17418007
    [No Abstract]   [Full Text] [Related]  

  • 52. [Visceral leishmaniasis mimicking Felty's syndrome in rheumatoid arthritis treated with methotrexate and etanercept].
    Ruffer N; Tomas NM; Schmiedel S; Jordan S; Kötter I
    Z Rheumatol; 2022 Apr; 81(3):240-243. PubMed ID: 34633502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Visceral leishmaniasis related to infliximab administration].
    Romaní-Costa V; Sánchez C; Moyá F; Estany C
    Enferm Infecc Microbiol Clin; 2004 May; 22(5):310. PubMed ID: 15207130
    [No Abstract]   [Full Text] [Related]  

  • 54. Visceral leishmaniasis as an unusual infectious complication in a patient with Crohn's disease treated with infliximab.
    Hernández M; González-Lama Y; Ramos A; Martínez-Ruiz R; Calvo M; Matallana V; Vera MI; Suarez C; Blázquez I; Abreu L
    Gastroenterol Hepatol; 2015; 38(6):411-2. PubMed ID: 25443540
    [No Abstract]   [Full Text] [Related]  

  • 55. Cutaneous leishmaniasis in a patient receiving infliximab.
    Hernández-Torres A; García-Vázquez E; Frías-Iniesta J; Herrero-Martínez JA; Gómez-Gómez J
    Scand J Infect Dis; 2013 Jul; 45(7):567-9. PubMed ID: 23270475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy.
    Bukan KB; Nardo-Marino A; Hagdrup C; Boennelycke M; Breinholdt MF; Schöllkopf C; Nielsen HV; El Fassi D
    Scand J Rheumatol; 2019 Jul; 48(4):342-343. PubMed ID: 30526204
    [No Abstract]   [Full Text] [Related]  

  • 57. Atypical clinical presentation of visceral leishmaniasis: a rare case without splenomegaly.
    Cunha MA; Antunes AG; Eufrasio de Azevedo MM; Rafael Maciel JF; Lacerda HG
    Trop Doct; 2019 Jul; 49(3):233-234. PubMed ID: 30895886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phaeohyphomycosis caused by Phaeoacremonium species in a patient taking infliximab.
    Mazzurco JD; Ramirez J; Fivenson DP
    J Am Acad Dermatol; 2012 Feb; 66(2):333-5. PubMed ID: 22243731
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention.
    Garcia-Vidal C; Rodríguez-Fernández S; Teijón S; Esteve M; Rodríguez-Carballeira M; Lacasa JM; Salvador G; Garau J
    Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):331-7. PubMed ID: 18797940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rhodococcus equi infection in a patient with Crohn's disease treated with infliximab.
    Guerrero C; Tort J; Pérez J; Andrés M; Espejo E
    J Infect; 2015 Jun; 70(6):689-90. PubMed ID: 25546345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.